Showing 301 results
  • Three flags fly outside a Novartis manufacturing facility
    Image
    lock
    Manufacturing / Image
    Novartis radioligand therapy (RLT) manufacturing facility

    Exterior view of our large-scale, state-of-the-art radioligand therapy (RLT) manufacturing facility in Indianapolis, Indiana, United States.

  • Two associates in full personal protective equipment stand at the production line
    Image
    lock
    Manufacturing / Image
    Radioligand therapy (RLT) production line

    Highly trained specialists on the production line of our radioligand therapy (RLT) manufacturing facility in Indianapolis, Indiana, United States.

  • An associate in personal protective equipment stands at a refrigerator examining a bag
    Image
    lock
    Manufacturing / Image
    Refrigeration room at a Novartis radioligand therapy (RLT) manufacturing facility

    Examining materials inside the refrigeration room of our radioligand therapy (RLT) manufacturing facility in Indianapolis, Indiana, United States.

  • Associate in full personal protective equipment using specialized equipment
    Image
    lock
    Manufacturing / Image
    Specialized equipment for the manufacture of radioligand therapy (RLT)

    Using specialized equipment on the production line at our radioligand therapy (RLT) manufacturing facility in Indianapolis, Indiana, United States.

  • Associate in full personal protective equipment conducting quality control testing
    Image
    lock
    Manufacturing / Image
    Quality control for environmental monitoring in radioligand therapy (RLT) manufacturing

    Conducting quality control at our state-of-the-art radioligand therapy (RLT) manufacturing facility in Indianapolis, Indiana, United States.

  • Novartis in Society Integrated Report 2023
    PDF
    lock
    Publications / Report
    Novartis in Society Integrierter Geschäftsbericht 2023

    The Novartis in Society Integrated Report covers our business, strategy and performance. It highlights progress against our ESG targets and describes how we create sustainable value for diverse stakeholders. It follows requirements of the Swiss Code of Obligations and various voluntary reporting frameworks and standards. View the online summary

  • Close up of a production specialist in a RLT manufacturing site in Indianapolis, Indiana, United States
    Video
    lock
    Manufacturing / B Roll
    Novartis Radioligand Therapy (RLT) Manufacturing

    B-roll footage of our large-scale, state-of-the-art radioligand therapy (RLT) manufacturing facility in Indianapolis, Indiana, United States.

  • Novartis Annual Report 2023 cover
    PDF
    lock
    Publications / Report
    Novartis Annual Report 2023

    This report, filed with the SIX Swiss Exchange in Switzerland, provides a comprehensive overview of Novartis, including our company structure, corporate governance and compensation practices. It also contains our operating and financial results, accompanied by audited annual financial statements.

  • Novartis in Society Integrated Report 2023
    PDF
    lock
    Publications / Report
    Novartis in Society Integrated Report 2023

    The Novartis in Society Integrated Report covers our business, strategy and performance. It highlights progress against our ESG targets and describes how we create sustainable value for diverse stakeholders. It follows requirements of the Swiss Code of Obligations and various voluntary reporting frameworks and standards. View the online summary

  • Patrick Horber, M.D. - President, International, since December 1, 2023
    Image
    lock
    Leadership / Image
    Patrick Horber, M.D.

    President, International, since December 1, 2023

  • Patrick Horber, M.D. - President, International, since December 1, 2023
    Image
    lock
    Leadership / Image
    Patrick Horber, M.D.

    President, International, since December 1, 2023

  • Patrick Horber, M.D. - President, International, since December 1, 2023
    Image
    lock
    Leadership / Image
    Patrick Horber, M.D.

    President, International, since December 1, 2023